🔎 Trials Near Me

Pradžia › Osteosarkoma › New Jersey

Osteosarkoma klinikiniai tyrimai New Jersey

6 tyrimai dėl Osteosarkoma ieško dalyvių vietose New Jersey.

Miestai New Jersey

Oficialus tyrimo tekstas (anglų kalba)

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Hackensack University Medical Center, Hackensack
Renkami dalyviai1/2 fazė
Iki 26 metų · Visoms lytims · Atnaujinta 2026-09-03 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Hackensack University Medical Center, Hackensack
Renkami dalyviai1/2 fazė
Iki 30 metų · Visoms lytims · Atnaujinta 2026-09-03 · NCT06541262

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Saint Peter's University Hospital, New Brunswick
  • ir dar 2
Renkami dalyviai3 fazė
Iki 50 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT05235165

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Hackensack University Medical Center, Hackensack
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

  • Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent and Followup), Middletown
Renkami dalyviaiStebimasis tyrimas
Amžius 4 ir vyresni · Visoms lytims · Atnaujinta 2026-04-17 · NCT03442465

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale
Renkami dalyviai2 fazė
Amžius nuo 6 iki 49 · Visoms lytims · Atnaujinta 2026-03-17 · NCT07477457

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.